Global Age-Related Macular Degeneration (AMD) Market 2014-2018

About AMD

AMD is defined as the deterioration of the eye's macula. The macula is a small area in the retina that is responsible for central vision. The exact etiology of AMD is unknown. There are two types of macular degeneration: wet and dry. Wet AMD occurs when tiny abnormal blood vessels begin growing behind the retina toward the macula. Dry AMD occurs when small, yellowish deposits called drusen begin accumulating beneath the macula. While a number of treatments are available for wet AMD, there is no treatment available at the moment for dry AMD.

TechNavio's analysts forecast the Global AMD market will grow at a CAGR of 6.62 percent over the period 2013-2018.

Covered in this Report

The Global AMD market can be divided into two segments: Dry AMD and Wet AMD. This report covers the present scenario and the growth prospects of the Global AMD market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various therapies used in the treatment of AMD.

TechNavio's report, the Global AMD Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global AMD market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

• Americas 

• EMEA        

• APAC

Key Vendors

• Bayer AG 

• F. Hoffmann-La Roche Ltd.

• Novartis AG 

• Regeneron Pharmaceuticals Inc.

Other Prominent Vendors

 

• Acucela Inc.

• Advanced Cell Technology Inc.

• Alexion Pharmaceuticals Inc.

• Alimera Sciences Inc.

• Allergen Inc.

• Allergo Opthalmics LLC

• Avalanche Biotechnologies Inc.

• Gilead Sciences Inc.

• GlaxoSmithKline plc

• Icon Bioscience Inc.

• Intellect Neurosciences Inc.

• Lpath Inc.

• Neurotech Pharmaceuticals Inc.

• Opthotech Corp.

• OSI Pharmaceuticals Inc.

• Oxigene Inc.

• PanOptica Inc.

• Pfizer Inc.

• Santen Pharmaceutical Co. Ltd.

• StemCells Inc.

• Synthetic Biologics Inc.

• Thrombogenics NV

• Valeant Pharmaceuticals International Inc.

Key Market Driver

• Increase in Aging Population.

• For a full, detailed list, view our report.

Key Market Challenge

• Increase in Off Label Use.

• For a full, detailed list, view our report.

Key Market Trend

• Increase in Awareness of AMD.

• For a full, detailed list, view our report.

Key Questions Answered in this Report

• What will the market size be in 2018 and what will the growth rate be?

• What are the key market trends?

• What is driving this market?

• What are the challenges to market growth?

• Who are the key vendors in this market space?

• What are the market opportunities and threats faced by the key vendors?

• What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.